Literature DB >> 21680084

How well can you actually predict which non-muscle-invasive bladder cancer patients will progress?

Richard J Sylvester.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21680084     DOI： 10.1016/j.eururo.2011.06.001

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  19 in total

1.  High CD4⁺ T cell density is associated with poor prognosis in patients with non-muscle-invasive bladder cancer.

Authors:  Qinglei Zhang; Chongli Hao; Guangzhou Cheng; Lei Wang; Xiang Wang; Chang Li; Juhui Qiu; Kejia Ding
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  Ki-67 and Cell Cycle Regulators p53, p63 and cyclinD1 as Prognostic Markers for Recurrence/ Progression of Bladder Urothelial Carcinoma.

Authors:  Saba El-Gendi; Ghada Abu-Sheasha
Journal:  Pathol Oncol Res       Date:  2017-05-09       Impact factor: 3.201

3.  [Secondary prevention in patients with superficial urothelial carcinoma].

Authors:  T J Schnöller; F Zengerling; C Hirning; F Jentzmik
Journal:  Urologe A       Date:  2015-07       Impact factor: 0.639

4.  Human epidermal growth factor receptor 2: a significant indicator for predicting progression in non-muscle-invasive bladder cancer especially in high-risk groups.

Authors:  Weihong Ding; Shijun Tong; Yuancheng Gou; Chuanyu Sun; Hong Wang; Zhongqing Chen; Jun Tan; Ke Xu; Guowei Xia; Qiang Ding
Journal:  World J Urol       Date:  2015-04-18       Impact factor: 4.226

5.  Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation.

Authors:  M Gierth; H M Fritsche; H Buchner; M May; A Aziz; W Otto; C Bolenz; L Trojan; E Hermann; A Tiemann; S C Müller; J Ellinger; S Brookman-May; C G Stief; D Tilki; P Nuhn; T Höfner; M Hohenfellner; A Haferkamp; J Roigas; M Zacharias; W F Wieland; H Riedmiller; S Denzinger; P J Bastian; M Burger
Journal:  World J Urol       Date:  2013-06-05       Impact factor: 4.226

6.  p53 Status correlates with the risk of recurrence in non-muscle invasive bladder cancers treated with Bacillus Calmette-Guérin: a meta-analysis.

Authors:  Xiaofeng Zhou; Guan Zhang; Ye Tian
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

7.  Letter to the editor.

Authors:  Sławomir Poletajew; Piotr Radziszewski
Journal:  Cent European J Urol       Date:  2014

8.  The prognostic value of family history among patients with urinary bladder cancer.

Authors:  Lieke Egbers; Anne J Grotenhuis; Katja K Aben; J Alfred Witjes; Lambertus A Kiemeney; Sita H Vermeulen
Journal:  Int J Cancer       Date:  2014-07-09       Impact factor: 7.396

9.  Prognostic relevance of urinary bladder cancer susceptibility loci.

Authors:  Anne J Grotenhuis; Aleksandra M Dudek; Gerald W Verhaegh; J Alfred Witjes; Katja K Aben; Saskia L van der Marel; Sita H Vermeulen; Lambertus A Kiemeney
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

10.  Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models.

Authors:  E López de Maturana; A Picornell; A Masson-Lecomte; M Kogevinas; M Márquez; A Carrato; A Tardón; J Lloreta; M García-Closas; D Silverman; N Rothman; S Chanock; F X Real; M E Goddard; N Malats
Journal:  BMC Cancer       Date:  2016-06-03       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.